Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

12.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Light-induced acceleration of specific binding between CEACAM-5 and antibodies for early detection of colorectal cancer.

Nanoscale horizons·2026
Same author

Tissue-derived extracellular vesicle profiling identifies GLUT1 enabling ultrasensitive circulating quantification and early detection of non-small cell lung cancer.

Clinical and translational medicine·2026
Same author

Dual-specific phosphatase 5 (DUSP5), upregulated in lung adenocarcinoma, as a potential therapeutic target for lung cancer.

Biochemical and biophysical research communications·2025
Same author

PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma.

Cancer science·2025
Same author

Mir-494-3p enhances aggressive phenotype of non-small cell lung cancer cells by regulating SET/I2PP2A.

Scientific reports·2025
Same author

Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.

Journal of gastroenterology·2024
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.5K

A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data.

Rong Fu1, Pei Wang2, Weiping Ma2

  • 1Department of Biostatistics, University of Washington, Seattle, Washington, U.S.A.

Biometrics
|June 9, 2016
PubMed
Summary
This summary is machine-generated.

MutRSeq is a new statistical method for detecting differentially expressed single nucleotide variants (SNVs) using RNA-seq data. It identifies genes with nonsynonymous mutations in breast cancer tumors, outperforming existing methods.

Keywords:
Allele-specific expressionBreast cancer tumorsDifferential expressionLikelihood ratio testRNA-seq

More Related Videos

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

6.5K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.5K
Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

6.5K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Area of Science:

  • Genomics
  • Bioinformatics
  • Statistical Genetics

Background:

  • RNA sequencing (RNA-seq) provides valuable insights into gene expression and mutation profiles.
  • Detecting differentially expressed single nucleotide variants (SNVs) is crucial for understanding disease mechanisms.
  • Existing methods may not fully capture complex mutation and expression patterns.

Purpose of the Study:

  • To introduce MutRSeq, a novel statistical method for identifying differentially expressed SNVs from RNA-seq data.
  • To develop a method capable of jointly modeling mutation events and RNA-seq read counts.
  • To enable the detection of changes in both overall and allele-specific expression patterns.

Main Methods:

  • MutRSeq employs a hierarchical likelihood approach to model mutation events and RNA-seq read counts.
  • A likelihood ratio-based test statistic is introduced for detecting differential expression.
  • The method supports joint testing of multiple mutations within a gene or pathway.

Main Results:

  • Simulation studies demonstrate that MutRSeq offers superior statistical power compared to existing methods.
  • The method effectively identifies changes in allele-specific expression patterns.
  • Application to breast cancer data revealed differentially expressed genes with nonsynonymous mutations.

Conclusions:

  • MutRSeq provides a powerful new tool for analyzing SNVs in RNA-seq data.
  • The method enhances the ability to detect biologically significant mutations and expression changes.
  • This approach has potential applications in cancer research and personalized medicine.